Many biotech stocks have choked in 2021. The biggest exchange-traded funds that track the biotech industry are in negative territory year to date. But that doesn’t mean that some individual stocks aren’t poised to deliver strong returns going forward.
We asked three Motley Fool contributors which biotech stocks they think could make investors richer in December (and beyond). Here’s why they chose Moderna (NASDAQ: MRNA), Seagen (NASDAQ: SGEN), and Vertex Pharmaceuticals (NASDAQ: VRTX).